Extremely interesting. Maybe the FDA needs a new classification and evaluation methodology for personalized genetically engineered cures. Most of these treatm

Extremely interesting. Maybe the FDA needs a new classification and evaluation methodology for personalized genetically engineered cures. Most of these treatments are not going to be useful to anyone other than the individual they are designed for. We need a Pharma Johns as in the Peripheral.